Giulio Francolini, Saverio Caini, Vanessa Di Cataldo, Pietro Garlatti, Michele Aquilano, Niccolò Bertini, Alessio Bruni, Gianluca Ingrosso, Rolando Maria D'Angelillo, Luca Tagliaferri, Matteo Augugliaro, Luca Triggiani, Silvana Parisi, Lorenzo Masieri, Riccardo Campi, Gabriele Simontacchi, Richard K. Valicenti, Chad Tang, Lorenzo Livi. "ARTO trial (NCT03449719): Long-term overall survival analysis from a randomized phase II trial testing the benefit of stereotactic body radiotherapy addition to abiraterone acetate in oligometastatic castrate resistant prostate cancer patients.." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.7_suppl.151